AMICUS THERAPEUTICS, INC. (26) | Business Finance (6)
Browse by Subcategory
Recent Contracts
-
Form of Exchange Agreement Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on June 19, 2019)
-
Underwriting Agreement, dated May 30, 2019, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and SVB Leerink LLC
(Filed With SEC on May 31, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on May 22, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on March 13, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on February 8, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on January 24, 2019)
